HYBRID EVENT: You can participate in person at Baltimore, Maryland, USA or Virtually from your home or work.
Coronavirus (COVID-19) & Pandemic Vaccines
Coronavirus disease (COVID-19) is an infectious disease originated by a newly discovered virus known as coronavirus. Coronavirus is a family of virus that causes illness such as respiratory diseases or gastrointestinal diseases. Respiratory disease can range from the common cold to more severe diseases e.g.:
- Severe Acute Respiratory Syndrome (SARS-CoV)
- Middle East Respiratory Syndrome (MERS-CoV)
This virus name is as per its appearance under a microscope. The virus contains of a core of genetic materials enclosed by an envelope with protein spikes. This gives it the appearance of a crown. The meaning of the word corona is “crown” in Latin.
Committee Members
Regina Au
BioMarketing Insight, United States
Khursheed Anwer
IMUNON, Inc., United States
Joe Smyser
The Public Good Projects, United States
Vincenzo Alfano
University of Napoli Parthenope, Italy IVC 2024 Speakers
Carly Contri
American Academy of Pediatrics, United States
Khursheed Anwer
IMUNON, Inc., United States
Sean Yanik
Johns Hopkins, United States
Yen Hung Chow
National Health Research Institutes, Taiwan
Ping Xie
Associate Professor , United StatesSubmit your abstract Today
Title : Evaluating community-based vaccine initiatives with power BI
Carly Contri, American Academy of Pediatrics, United States
Title : The power of cultural validation when empowering community immunity
Julissa Soto, Julissa Soto Latino Health Equity Consulting, United States
Title : High prevalence of zero-dose children in underserved and special setting populations in Ethiopia using a generalize estimating equation and concentration index analysis.
Gashaw Andargie Biks, Project HOPE, Ethiopia
Title : Your vaccine attitude determines your altitude. What are the determinants of attitudes toward vaccination
Vincenzo Alfano, University of Napoli Parthenope, Italy
Title : Current Investments and Future Directions of Biomedical Advanced Research and Development Authority’s CBRN Vaccines Portfolio
Lindsay Parish, BARDA, United States
Title : Evaluation of vaccine preventable disease VPD surveillance system in Haryana state, India.
Prasoon Sheoran, Directorate of Health and Family Welfare, India
Title : Adaptation of local rabies virus isolates to high growth titer to develop vaccine strain in Ethiopia
Abebe Aga, Armauer Hansen Research Institute, Ethiopia
Title : Antibiotic resistance present situation in Bangladesh at different districts
Ismail Hossain, Globe Biotech, Bangladesh
Title : Spatial distribution of zero-dose children in Ethiopia: Evidence for a targeted intervention from a large-scale evaluation survey
Fisseha Shiferie Tadesse, Project HOPE, Ethiopia
Title : Impact of vaccination on the risk of severe forms of COVID -19 among elderly patients hospitalized in a Tunisian university hospital
Souhir Ayadi, Faculty of Medicine, Tunisia